Xelobine

Capecitabine

Description
Capecitabine is a fluoropyrimidine carbamate with antineoplastic activity. It is an orally administered systemic prodrug of 5'-deoxy-5-fluorouridine (5'-DFUR) which is converted to 5-fluorouracil.

Indications
Adjuvant Colon Cancer
- Patients with Dukes' C colon cancer
Metastatic Colorectal Cancer
- First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred
Metastatic Breast Cancer
- In combination with docetaxel after failure of prior anthracycline containing therapy
- As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen

Supply
Xelobine 500 tablet: Each commercial box contains 30 tablets in Alu-Alu blister pack.